Get our Free Patent Expiration Newsletter

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Harvard Business School
Johnson and Johnson

Last Updated: January 28, 2020

DrugPatentWatch Database Preview

Avelumab - Biologic Drug Details

See Plans and Pricing

« Back to Dashboard

Summary for avelumab
Suppliers: see list1
Recent Clinical Trials: See clinical trials for avelumab
Recent Clinical Trials for avelumab

Identify potential brand extensions & biosimilar entrants

Institut Paoli-CalmettesPhase 2
Southwest Oncology GroupPhase 2
Oncolytics BiotechPhase 2

See all avelumab clinical trials

Patent Text Search: US Patents for avelumab

These patents were identified by searching patent claims

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.